Negativation of PD-L1 Postoperatively in Initially Inoperable Stage III Non-Small Cell Lung Cancer Treated with Pembrolizumab: Two Case Reports

Stage III non-small cell lung cancer is a border line stage between localized and metastatic disease. PDL-1 is gaining an important role in the therapeutic arsenal of lung cancer, the most frequent cancer worldwide. We report for the first time a negativation of PDL-1 status in 2 cases of stage IIIA...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasr, Fadi, Al Ghoche, Ahmad, Eid, Roland, Nasr, Lewis, Diab, Saada, Hallit, Souheil, Riachi, Moussa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587214/
https://www.ncbi.nlm.nih.gov/pubmed/31244645
http://dx.doi.org/10.1159/000500671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587214/
https://www.ncbi.nlm.nih.gov/pubmed/31244645
http://dx.doi.org/10.1159/000500671

Ejemplares similares